Overview

Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency

Status:
Completed
Trial end date:
2013-08-05
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the clinical effect of TV-1106.
Phase:
Phase 2
Details
Lead Sponsor:
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries, Ltd.
Treatments:
Hormones